Antibiotic therapy and outcome from immune-checkpoint inhibitors

Sensitivity to immune checkpoint inhibitor (ICPI) therapy is governed by a complex interplay of tumor and host-related determinants. Epidemiological studies have highlighted that exposure to antibiotic therapy influences the probability of response to ICPI and predict for shorter patient survival ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinato, David J., Gramenitskaya, Daria, Altmann, Daniel M., Boyton, Rosemary J., Mullish, Benjamin H., Marchesi, Julian R., Bower, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836427/
https://www.ncbi.nlm.nih.gov/pubmed/31694714
http://dx.doi.org/10.1186/s40425-019-0775-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836427/
https://www.ncbi.nlm.nih.gov/pubmed/31694714
http://dx.doi.org/10.1186/s40425-019-0775-x

Ejemplares similares